Helixmith ranked among the top searched stocks for 7 days in the past month.


As of 10:31 AM on the 22nd, Helixmith is trading at 20,200 KRW, down 1.46% from the previous day. This represents a 51.67% decrease compared to September 18. Helixmith is known as a company specializing in the development of new drugs centered on gene therapy.

Today, foreigners have net purchased 30,000 shares of Helixmith, and institutions have net purchased 9,000 shares, according to provisional data. Over the past 5 days, individual investors have net purchased 79,915 shares, while foreigners and institutions have net purchased 117,232 shares and net sold 153,097 shares, respectively.


On October 21, Helixmith became a market issue with the headline "'260 billion KRW private equity fund investment' clarification leads to 'rebound'."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing